News about Biotechnology, Pharmaceutical and Healthcare
Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors.
Ryan ChavisMars Chocolate North America this week unveiled a number of new products, along with some new consumer promotions and merchandising displays at the National Confectioners Association Sweets and Snacks Expo in Chicago. read more
Antoinette AlexanderHitting mass and drug retailers is the Love2Love Bluebell + White Tea fragrance, Coty has announced. read more
Michael JohnsenInjuries from fashionable high heels are on the rise, but sales of footcare devices are relatively flat. read more
Antoinette AlexanderSanrio, parent company of Hello Kitty, and The Mentholatum Co.'s Softlips Cube 5-in-1 Lip Care will partner to launch a new lip balm collection beginning in July. read more
Kroger has raised almost $12 million in the past five years to support the USO. read more
Michael JohnsenThe U.K.'s CMA feels that Reckitt-Benckiser acquisition of K-Y personal lubricants may lead to higher prices across the category. read more
The Royal Pharmaceutical Society says financial position remains ‘very strong’.
Combination therapy with two drugs that target the most common genetic cause of cystic fibrosis (CF) has been found to improve lung function in patients with the disease.
Antoinette AlexanderThe American Pharmacists Association Foundation’s diabetes management solution, the Patient Self-Management Credential for Diabetes, was highlighted May 18 at the Healthcare Leadership Council’s wellness briefing entitled, Controlling Diabetes: Innovations in Therapies and Care.
Antoinette AlexanderThe Phoenix House New England, a nonprofit treatment provider, will host on June 2 the 14th annual New England Public Service Award Luncheon at the Omni Providence Hotel, honoring Helena Foulkes, EVP, CVS Health, and president, CVS/pharmacy, for her leadership and contributions to the community. read more
Big Pharma is not the only slow moving behemoth involved in the CRISPR/Cas9 revolution with a US team citing the gene editing tech as key to its efforts to resurrect the woolly mammoth.
Danaher's acquisition of Pall will not change the competitive landscape in the bioprocessing tech industry says Thermo Fisher, as it earmarks $10bn for further M&A activity.
Eric Lerner May 4, 2015 Health Care Without Harm Across the United States, a growing number of health systems are taking action to address climate change by limiting greenhouse gas emissions, reducing energy use, and investing in renewables. Two recent success stories highlight this trend. In November, Gundersen Health became the first energy independent health system in the nation. Last mo...
The EMA has recommended eight medicines for approval in a round of reviews, including four new cancer indications. Amgen’s Repatha (evolocumab), the first monoclonal antibody approved to treat high cholesterol, could be a new option for patients who are unable to control their cholesterol using statins. The drug is also indicated for homozygous familial hypercholesterolaemia, a rare inherited di...
The forum will bring together professionals in innovation in pharmaceutical manufacturing on 27 and 28 October
Plus, the Institute for Bioengineering of Catalonia has received the ‘Severo Ochoa’ distinction
In the previous edition, another Catalan businessman from the biotech sector won in the Business category.
Visit Fritch at ACHEMA 2015: Hall 4.1 • Stand J 49 FRITSCH • Milling and Sizing, an internationally respected manufacturer of application-oriented laboratory instruments for sample preparation and particle sizing, is again one step ahead. Convince yourself and discover the FRITSCH innovations live during ACHEMA 2015: Hall 4.1 • Stand J49!
University of Barcelona to give three €1,500 grants to attend
The company has signed a collaboration agreement with Research Triangle, in California
The company has raised €100,000 to research personalized cancer treatments
The company has acquired new technology to expand its R&D and quality control services for the biopharmaceutical industry
Top science academics have launched an initiative to consider emerging human gene-editing tools such as CRISPR-Cas9.
Society restates concern over lack of defence for hospital pharmacists in official response to government consultation.
Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund reviews. The German firm’s Stivarga (regorafenib) for the treatment of gastrointestinal stromal tumours, will remain on the Fund, while Eisai’s breast cancer medicine Halaven (eribulin) and Lilly’s lung cancer drug Alimta (pemetrexed) lost their appeals and will be dropped in July. read more